4.7 Review

Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease

Olimpo Garcia-Beltran et al.

Summary: Protein aggregation, mitochondrial dysfunction, iron dyshomeostasis, increased oxidative damage and inflammation are common features of Parkinson's disease and other neurodegenerative disorders. Current treatments aim to relieve symptoms, but no treatments to stop disease progression are available. The use of multifunctional compounds to target key components of neurodegeneration has been proposed. This review discusses the molecular basis of Parkinson's disease and clinical trials using single-target drugs, as well as the potential of multifunctional compounds for treatment.

ANTIOXIDANTS (2023)

Review Cell Biology

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

Joseph Nowell et al.

Summary: Therapeutic strategies for neurodegenerative disorders have had limited success by targeting individual aspects of the disease pathogenesis. However, a link between Alzheimer's disease (AD)/Parkinson's disease (PD) and type 2 diabetes mellitus has opened up a promising avenue for repurposing antidiabetic agents in the treatment of these disorders. Targeting cerebral insulin signalling and brain incretin receptors have shown potential in preclinical and clinical studies, with approved diabetic compounds improving motor symptoms of PD and preventing neurodegenerative decline. Additional approved diabetic treatments are also being investigated for deployment in PD and AD treatment. This comprehensive review explores several promising antidiabetic agents for the treatment of AD and PD.

AGEING RESEARCH REVIEWS (2023)

Editorial Material Pharmacology & Pharmacy

Lecanemab: First Approval

Sheridan M. Hoy

Summary: Lecanemab is a humanized immunoglobulin gamma 1 (IgG1) antibody developed by Eisai for the treatment of Alzheimer's disease. It targets aggregated forms of amyloid-beta peptide. The drug has received accelerated approval in the USA and is undergoing regulatory review in the EU, Japan, and China.

DRUGS (2023)

Editorial Material Clinical Neurology

Parkinson's disease: a never ending story

Heinz Reichmann et al.

JOURNAL OF NEURAL TRANSMISSION (2023)

Review Nutrition & Dietetics

New Pieces for an Old Puzzle: Approaching Parkinson's Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics

Lorena Ortega Moreno et al.

Summary: Parkinson's disease (PD) is a severe neurodegenerative disease with disabling motor alterations diagnosed at a late stage, along with early non-motor symptoms like constipation. Current treatments only reduce motor symptoms with drawbacks, so new approaches targeting PD etiopathogeny and biomarkers are needed. Gastrointestinal origins of PD, modulation of gut microbiome, and lipidomics as a tool for personalized analysis show promise in understanding and treating PD.

NUTRIENTS (2023)

Review Neurosciences

Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review

Xiaoman Yang et al.

Summary: Many neurodegenerative diseases are characterized by the accumulation of pathogenic proteins and abnormal organelle localization, which are likely due to axonal transport deficits. This review investigated mechanisms underlying the development of axonal transport deficits in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, and Huntington's disease. These mechanisms include changes in motor proteins, microtubules, and cargoes. Further research is needed to determine disease-specific axonal transport defects and their suitability as therapeutic targets.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2023)

Review Neurosciences

The potential of the gut microbiome for identifying Alzheimer's disease diagnostic biomarkers and future therapies

Yu Zhan et al.

Summary: Recent research has shown that the gut microbiome can influence gastrointestinal and brain disorders like Alzheimer's disease. Although the exact pathogenesis of Alzheimer's disease is still not fully understood, it is believed that the gut microbiome plays a role in its development. Researchers are currently trying to find reliable biomarkers for early diagnosis and monitoring of disease progression.

FRONTIERS IN NEUROSCIENCE (2023)

Article Medicine, General & Internal

Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)

Marcos Tadashi Kakitani Toyoshima et al.

Summary: This study aimed to evaluate the reliability of HbA1c and fructosamine as glycemic biomarkers in patients with type 2 diabetes and cancer. The results showed that fructosamine and HbA1c can be used as glycemic biomarkers in these patients, even in the presence of anemia, hypoproteinemia, or undergoing chemotherapy.

CLINICS (2023)

Article Microbiology

Administration of Human Derived Upper gut Commensal Prevotella histicola delays the onset of type 1 diabetes in NOD mice

Eric Marietta et al.

Summary: This study found that oral administration of P. histicola delayed the onset of T1D in NOD mice by increasing the levels of regulatory T cells in the pancreatic lymph nodes. This preliminary work supports the potential use of P. histicola as a therapy for T1D.

BMC MICROBIOLOGY (2022)

Review Food Science & Technology

Advanced glycation end products in food and their effects on intestinal tract

Chenzhipeng Nie et al.

Summary: With the improvement of living standards, harmful substances in diet have become a serious threat to people's health. Advanced glycation end products (AGEs) formed in processed food have been significantly associated with chronic diseases and sparked widespread controversy in academia. This review summarizes the factors influencing the production of dietary AGEs, their metabolism and absorption, and discusses their effects on intestinal health and gut microbiota.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Article Medical Laboratory Technology

Glycated Albumin for the Diagnosis of Diabetes in US Adults

Michael Fang et al.

Summary: Glycated albumin has excellent diagnostic performance in identifying undiagnosed diabetes in the general population, suggesting its potential usefulness as an alternative test for diagnosing diabetes when standard tests are unavailable.

CLINICAL CHEMISTRY (2022)

Article Endocrinology & Metabolism

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

Juraj Koska et al.

Summary: This study evaluated the association of a multicomponent AGE panel with decline in kidney function in type 2 diabetes, and demonstrated its utility in predicting long-term decline in renal function.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Association between Helicobacter pylori infection and the risk of type 2 diabetes mellitus based on a middle-aged and elderly Chinese population

Jielin Zhou et al.

Summary: This study investigated the association between Helicobacter pylori (Hp) infection and type 2 diabetes mellitus (T2DM) in the middle-aged and elderly Chinese population. The findings showed that Hp infection is associated with an increased risk of T2DM, and this association could be further elevated by the presence of traditional risk factors such as age, obesity, and hypertension.

ENDOCRINE JOURNAL (2022)

Review Biochemistry & Molecular Biology

The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes

Matthew Snelson et al.

Summary: There is increasing evidence for the role of intestinal permeability in the pathogenesis of diabetes, and the binding of advanced glycation endproducts to RAGE receptor may trigger proinflammatory signaling cascade, leading to intestinal inflammation and increased permeability, thus contributing to the development of diabetes complications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD

Moeko Noguchi-Shinohara et al.

Summary: This study found significant associations between diabetes and hyperglycemia with Alzheimer's disease, even in individuals with prediabetes.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Cardiac & Cardiovascular Systems

Is dietary intake of advanced glycation end products associated with mortality among adults with diabetes?

Alain K. Koyama et al.

Summary: This study aimed to investigate the association between dietary advanced glycation end products (AGEs) intake and mortality. The analysis of 5,474 adults with diabetes showed that higher AGEs intake was associated with lower concordance to dietary guidelines. However, there was no significant association between AGEs intake and all-cause mortality.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Article Nutrition & Dietetics

In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration

Marialena Chrysanthou et al.

Summary: This review explores the potential role of AGEs in neuroinflammation and neurodegeneration, discussing in vitro methodologies, current findings, and challenges in the research field. The article provides an overview of the concepts linking AGEs to neurodegeneration and highlights the need for further research to elucidate their underlying modes of action.

NUTRIENTS (2022)

Article Endocrinology & Metabolism

The activity of glyoxylase 1 is regulated by glucose-responsive phosphorylation on Tyr136

Fabiola Garcia Cortizo et al.

Summary: The study demonstrates that post-translational modifications, specifically the phosphorylation of Glo1 at Tyrosine 136, can enhance Glo1 activity for detoxifying MG. However, high glucose levels lead to decreased Glo1 activity, resulting in elevated MG levels and potentially initiating a detrimental positive feedback loop contributing to diabetic complications.

MOLECULAR METABOLISM (2022)

Article Endocrinology & Metabolism

Dietary Advanced Glycation End Products Shift the Gut Microbiota Composition and Induce Insulin Resistance in Mice

Jiao Wang et al.

Summary: This study explored the association between gut microbiota characteristics and glycometabolic profiles in mice fed high-AGE diets. The results showed that high-AGE diets altered the composition and structure of gut microbiota, and induced insulin resistance in mice. The loss of butyrate-producing bacteria might impair the colonic epithelial barrier, leading to chronic low-grade inflammation.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Article Endocrinology & Metabolism

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC

Vincent M. Monnier et al.

Summary: This study assessed the impact of glycemic control on pAGEs and their association with subsequent microvascular disease. The results showed that certain pAGEs decreased with intensive glycemic control and were correlated with HbA1c. These pAGEs were also associated with the risk of various microvascular complications in patients with diabetes, and the association with diabetic kidney disease remained significant even after adjustment for HbA1c.

BMJ OPEN DIABETES RESEARCH & CARE (2022)

Article Clinical Neurology

Effects of an low carbohydrate/healthy fat/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot study

Melanie M. Tidman et al.

Summary: Evaluated the effects of a low carbohydrate/healthy fat/ketogenic diet on adults with Parkinson's disease. Showed positive trends in biomarkers and anxiety symptoms, but further research is needed.

NEURODEGENERATIVE DISEASE MANAGEMENT (2022)

Article Biochemistry & Molecular Biology

Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer's Disease Model

Joel Frandsen et al.

Summary: Cannabidiol, a nonpsychoactive phytocannabinoid derived from Cannabis sativa, possesses various pharmacological activities, including anti-inflammatory, antioxidant, and neuroprotective effects. This research paper investigates the impact of Cannabidiol on cerebellar neurons and Caenorhabditis elegans strains, and reveals that it can enhance the neural glyoxalase pathway, thereby preventing cellular damage caused by methylglyoxal and extending the lifespan and survival of C. elegans, including a transgenic strain modeling Alzheimer's disease.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Endocrinology & Metabolism

Hemoglobin glycation index predicts renal function deterioration in patients with type 2 diabetes and a low risk of chronic kidney disease

Chih-Hung Lin et al.

Summary: This study found that the hemoglobin glycation index (HGI) can predict renal function deterioration in patients with type 2 diabetes and a low risk of chronic kidney disease (CKD). This finding is important for early detection and intervention of kidney function problems in clinical practice.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Review Environmental Sciences

Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus

Md Tanvir Kabir et al.

Summary: This review summarizes the potential of dopamine agonists, such as bromocriptine, in the treatment of type 2 diabetes mellitus (T2DM), highlighting their effectiveness in reducing blood glucose levels, improving lipid profiles, and reducing cardiovascular risk.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)

Article Environmental Sciences

Investigating the molecular mechanisms of glyoxal-induced cytotoxicity in human embryonic kidney cells: Insights from network toxicology and cell biology experiments

Dan Liu et al.

Summary: Glyoxal exerts cytotoxicity on HEK293 cells through oxidative stress, AGEs-RAGE pathway, cellular inflammation, DNA damage, and mitochondrial apoptosis.

ENVIRONMENTAL TOXICOLOGY (2022)

Article Biochemistry & Molecular Biology

Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives

Jasvinder Singh Bhatti et al.

Summary: Type 2 diabetes is a rapidly rising metabolic disorder characterized by insulin resistance and beta-cell dysfunction. High blood sugar levels lead to the production of reactive oxygen species (ROS) and oxidative stress, which contribute to the development and progression of the disease. Antioxidants can neutralize ROS and maintain bodily homeostasis. However, the efficacy of antioxidant therapies in preventing diabetes is conflicting in clinical evidence.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Biochemistry & Molecular Biology

Biophysical changes in methylglyoxal modified fibrinogen and its role in the immunopathology of type 2 diabetes mellitus

Shahida Perween et al.

Summary: In type 2 diabetes mellitus, non-enzymatic glycosylation of proteins leads to the generation of AGEs, which contribute to diabetes-associated complications. Methylglyoxal alters the structure of fibrinogen and increases its immunogenicity, potentially triggering an autoimmune response in patients with type 2 diabetes.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Biochemistry & Molecular Biology

Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors

Naila Rabbani et al.

Summary: The abnormal accumulation of methylglyoxal has been linked to aging and disease. Glyoxalase 1 plays a major role in the metabolism of methylglyoxal. Small molecule inducers of Glyoxalase 1 have been developed to alleviate dicarbonyl stress and treat type 2 diabetes. Moreover, cell permeable Glyoxalase 1 inhibitor prodrugs show potential as a treatment for cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

Azad Farzadfard et al.

Summary: This study reveals the inhibitory effect of glycation on alpha-synuclein fibril formation and provides insights into its molecular mechanism. Glycation primarily affects the elongation of alpha-synuclein and has a modest impact on oligomerization.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Food Science & Technology

Dietary Advanced Glycation End-Products Affects the Progression of Early Diabetes by Intervening in Carbohydrate and Lipid Metabolism

Yi Wu et al.

Summary: This study found that thermally processed diets with high advanced glycation end-products (AGEs) are associated with diabetes and its complications by modulating carbohydrate and lipid metabolism. Switching to a lower AGEs diet can alleviate most symptoms except for the composition of gut microbiota.

MOLECULAR NUTRITION & FOOD RESEARCH (2022)

Article Clinical Neurology

Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study)

Merve Uyar et al.

Summary: This study evaluated the relationship between diabetes and HbA1c levels with neuroaxonal damage and cognitive impairment in Parkinson's disease patients. The results showed that diabetes and high HbA1c levels were associated with increased neuroaxonal damage and cognitive impairment.

MOVEMENT DISORDERS (2022)

Article Neurosciences

Rapamycin Pretreatment Attenuates High Glucose-induced Alteration of Synaptic Transmission in Hippocampal Dentate Gyrus Neurons

Tianyue Jiang et al.

Summary: Neuropathy is a common complication in diabetes patients that leads to cognitive impairment. This study reveals that high glucose induces abnormalities in the electrophysiological characteristics of hippocampal dentate gyrus neurons, but pre-treatment with rapamycin can reverse these changes and improve synaptic transmission.

NEUROSCIENCE (2022)

Article Nutrition & Dietetics

Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults

Michal Schnaider Beeri et al.

Summary: This study investigated the associations between dietary-derived advanced glycation end products (AGEs) and cognitive decline in older adults. The results showed that higher levels of dietary AGEs were associated with a faster rate of cognitive decline, particularly in episodic memory and perceptual speed. These findings highlight the importance of diet in preventing late-life cognitive impairment.

NUTRIENTS (2022)

Article Nutrition & Dietetics

Dietary Advanced Glycation End Products in an Elderly Population with Diabetic Nephropathy: An Exploratory Investigation

Mieke Steenbeke et al.

Summary: The study found that a diet restricted in AGE consumption for two months did not affect AGE content in the body or sRAGE concentration in the blood. The impact of blood glucose levels appears to be more significant than the consumption of dAGEs.

NUTRIENTS (2022)

Article Immunology

Exploring the Causal Effect of Constipation on Parkinson's Disease Through Mediation Analysis of Microbial Data

Shih-Chen Fu et al.

Summary: The study found that gut dysbiosis plays a critical role in the pathogenesis of constipation-related Parkinson's disease, mainly through the reduction of SCFA-producing bacteria. Mediation analysis showed that up to 76.56% of the impact of constipation on Parkinson's disease was mediated through intestinal microbial alteration.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Editorial Material Neurosciences

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease

Song Li et al.

FRONTIERS IN NEUROSCIENCE (2022)

Review Pharmacology & Pharmacy

Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions

Chenyin Wang et al.

Summary: Emerging evidence suggests that the interaction between the gut microbiome and the brain plays a critical role in neurodegenerative diseases (NDs). This review highlights the advantages of using C. elegans as a model to study the microbe-host interaction in neurodegeneration. The role of bacterial amyloid proteins in promoting proteotoxicity and neurodegeneration is investigated, and the potential therapeutic strategy of targeting bacterial amyloid production is proposed.

FRONTIERS IN PHARMACOLOGY (2022)

Article Neurosciences

Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes

Ana Chegao et al.

Summary: This study found that MGO-induced glycation accelerates PD-like sensorimotor and cognitive alterations and increases the accumulation of α-synuclein in the brain. In addition, the study also found that MGO mainly affects glutamatergic signaling in the midbrain, which may be associated with PD and dopaminergic pathways.

NPJ PARKINSONS DISEASE (2022)

Article Nutrition & Dietetics

Sodium Ions Affect Pyrraline Formation in the Maillard Reaction With Lys-Containing Dipeptides and Tripeptides

Zhili Liang et al.

Summary: In this study, the effects of different dipeptide and tripeptide structures as well as NaCl on the formation of pyrraline and the glucose derivative 3-deoxyglucosone were compared. The results showed significant differences in pyrraline levels among different peptide structures at the same concentrations. Sodium ions appeared to facilitate the reaction by altering the electron density and charge distribution of the peptides.

FRONTIERS IN NUTRITION (2022)

Review Chemistry, Analytical

A Review of Electrochemical Sensors for the Detection of Glycated Hemoglobin

Zhikun Zhan et al.

Summary: Glycated hemoglobin (HbA1c) is a stable biomarker used to diagnose diabetes, and electrochemical sensors have been developed to detect HbA1c effectively. This review discusses the methods and trends in electrochemistry for HbA1c monitoring, including the detection of HbA1c or its hydrolyzed product fructosyl valine/fructosyl valine histidine (FV/FVH). The review provides insights into the principles, performance, and potential clinical applications of various electrochemical HbA1c sensors.

BIOSENSORS-BASEL (2022)

Article Endocrinology & Metabolism

Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complications

Krishna A. Adeshara et al.

Summary: This study aims to explore the relationship between the interaction of advanced glycation end products (AGEs) and receptor for advanced glycation end products (RAGE) with oxidative stress and inflammation in vascular complications of diabetes. The results showed that patients with diabetes had higher levels of glycation adducts, oxidative stress, and inflammation, especially in patients with nephropathy. This study provides the first evidence of the existence of four different RAGE isoforms in diabetes and complications.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

Article Biochemistry & Molecular Biology

Therapeutic Efficacy of Natural Product 'C-Phycocyanin' in Alleviating Streptozotocin-Induced Diabetes via the Inhibition of Glycation Reaction in Rats

Arbab Husain et al.

Summary: The study found that C-phycocyanin (C-PC) obtained from Plectonema species has antioxidant, antiglycation, and antidiabetic properties. In a diabetic rat model, C-PC administration decreased blood glucose, lipids, and liver and kidney function indices, while increasing body weight. C-PC also suppressed biochemical glycation markers, maintained the redox state, and protected tissue structures.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusion

Ana Belen Uceda et al.

Summary: Parkinson's disease is a prevalent neurodegenerative disorder characterized by the accumulation of insoluble Lewy bodies in neurons, leading to neuronal death. The main component of these Lewy bodies, alpha-synuclein, undergoes non-enzymatic post-translational modifications, which affect its aggregation and physiological function. Understanding these modifications is crucial for better understanding the mechanisms underlying diabetes-induced Parkinson's disease.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Editorial Material Medicine, Research & Experimental

Methylglyoxal and glyoxalase 1-a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes

Naila Rabbani

Summary: The study found increased exposure of diabetic patients to methylglyoxal (MG), and the glyoxalase system plays an important role in the development of insulin resistance and vascular complications of diabetes. Other advances include the discovery of a new metabolic stress and therapeutic methods.

CLINICAL SCIENCE (2022)

Article Chemistry, Applied

EGCG attenuates the neurotoxicity of methylglyoxal via regulating MAPK and the downstream signaling pathways and inhibiting advanced glycation end products formation

Yin He et al.

Summary: This study found that EGCG can attenuate MGO-induced nerve damage by regulating MAPK and downstream pathways, as well as inhibiting the formation of AGEs.

FOOD CHEMISTRY (2022)

Article Clinical Neurology

Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

Eric McDade et al.

Summary: This study reports the effectiveness of lecanemab in significantly reducing amyloid plaques and slowing clinical decline. The data indicate that rapid and pronounced amyloid reduction correlates with clinical benefit and potential disease-modifying effects.

ALZHEIMERS RESEARCH & THERAPY (2022)

Article Biochemistry & Molecular Biology

miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease

Long Wang et al.

Summary: This study identified miR-143-3p as a potential candidate for targeting DAPK1 in Alzheimer's disease. miR-143-3p inhibited the translation of DAPK1 and reduced tau phosphorylation, while promoting neurite outgrowth and microtubule assembly. It also decreased amyloid precursor protein phosphorylation and the generation of Aβ. Furthermore, miR-143-3p levels were downregulated and inversely correlated with DAPK1 expression in the hippocampus of AD patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's Disease

Shu-Mei Chen et al.

Summary: Alzheimer's disease is a common form of dementia in the aging population and the sixth leading cause of death in the world. This study used encapsulated cell therapy and antibody-releasing cells to treat Alzheimer's disease, and demonstrated its effectiveness in improving the disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

DJ-1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons

Melissa Conti Mazza et al.

Summary: Human DJ-1 is a cytoprotective protein that defends against oxidative stress and mitochondrial dysfunction, but its role as a deglycase is controversial. Our study suggests that DJ-1 is not a true deglycase and has minor effects in protecting neurons against methylglyoxal toxicity.

JOURNAL OF NEUROCHEMISTRY (2022)

Article Clinical Neurology

The association between urinary pentosidine levels and cognition in drug-naive patients with Parkinson's disease

Shusaku Omoto et al.

Summary: The study found that urinary levels of pentosidine were associated with motor severity and cognition in patients with Parkinson's disease. Urinary pentosidine levels increased with age and were negatively correlated with cognitive ability. The levels were also significantly correlated with age, disease stage, and overall cognitive function. These findings have important clinical implications and suggest that pentosidine may be a potential marker for cognitive impairment in early Parkinson's disease.

NEUROLOGICAL SCIENCES (2022)

Review Cell Biology

Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review

Abdullahi Tunde Aborode et al.

Summary: Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases are increasing with age. Current therapies only provide symptom relief and do not target underlying pathologies. Oxidative stress pathways offer potential drug targets and have led to the development of novel pharmacological therapies for neurodegenerative diseases.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Review Nutrition & Dietetics

The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders

Nathan M. D'Cunha et al.

Summary: This review examines the relationship between advanced glycation end products (AGEs) and neurocognitive and mental health disorders. Studies show that elevated circulating AGEs are associated with poorer cognitive function and increased risk of developing dementia, while higher skin AGE accumulation may be associated with mental disorders. The effects of AGEs are mediated by increased oxidative stress and neuroinflammation, and reducing dietary intake of AGEs may improve neurological and mental disorder outcomes.

NUTRIENTS (2022)

Article Nutrition & Dietetics

Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer's Disease-Related Pathologies in Wild-Type Mice

Mona Abdelhamid et al.

Summary: Probiotics, specifically Bifidobacterium breve MCC1274, have beneficial effects on brain function by improving memory and cognition through the microbiome-gut-brain axis. This study investigates the potential of B. breve MCC1274 to mitigate Alzheimer's disease-like pathologies in wild-type mice. The results show that oral administration of B. breve MCC1274 reduces A beta 42 levels, inhibits tau phosphorylation, decreases neuroinflammation, and improves synaptic protein levels in the hippocampus. These findings suggest that B. breve MCC1274 may have potential therapeutic effects for Alzheimer's disease.

NUTRIENTS (2022)

Review Nutrition & Dietetics

Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

Amelia K. Fotheringham et al.

Summary: Since the 1980s, the incidence of chronic kidney disease (CKD) has increased by almost 25%. This is partly due to changes in lifestyle and the global consumption of a western diet, which is high in energy, low in fruits and vegetables, and rich in animal protein and processed foods. These dietary trends have led to an increase in the consumption of advanced glycation end products (AGEs) and metabolic disorders, obesity, and diabetes, which contribute to the production of endogenous AGEs in the body. Excessive accumulation of AGEs can be pathologic through receptor-mediated and non-receptor-mediated pathways. AGEs are cleared by the kidneys, making them particularly susceptible to AGE-mediated damage, and high levels of circulating AGEs are associated with an increased risk of CKD and all-cause mortality. Individuals with significant loss of renal function have increased AGE burden, particularly in those with uremia, and there is evidence that lowering AGEs through diet or pharmacological inhibition may be beneficial for CKD. This review explores the pathways of AGE formation and regulation in the body, the impact of diet on endogenous AGE production and dietary AGE consumption, the contribution of AGEs to kidney disease, and the potential of AGE-targeted therapies for kidney disease.

NUTRIENTS (2022)

Article Environmental Sciences

Correlation between Glycation-Related Biomarkers and Quality of Life in the General Japanese Population: The Iwaki Cross-Sectional Research Study

Masaya Tsubokawa et al.

Summary: This study investigates the correlation between diabetes-related biomarkers and quality of life (QOL) in a Japanese population. The findings suggest that levels of diabetes-related biomarkers, particularly plasma pentosidine, are associated with QOL.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Review Endocrinology & Metabolism

Gut microbiota: A new target for T2DM prevention and treatment

Lulu Liu et al.

Summary: Type 2 diabetes mellitus (T2DM) is characterized by metabolic disorders and is associated with intestinal flora disorders and dysfunction involving multiple organs. Metabolites of the intestinal flora can affect insulin sensitivity and metabolic immune homeostasis. This paper reviews the changes in gut flora in T2DM and the mechanisms by which gut microbiota modulates metabolites affecting T2DM, providing a basis for early identification and targeted interventions.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Diagnostic Performance of Sex-Specific Modified Metabolite Patterns in Urine for Screening of Prediabetes

Zaifang Li et al.

Summary: In this study, a metabolomics-based strategy using urine samples was developed to identify sex-specific biomarkers for the diagnosis of impaired glucose tolerance. The diagnostic performance of this approach was found to be superior to conventional blood parameters.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Biology

Therapeutic Potential of Quercetin in the Management of Type-2 Diabetes Mellitus

Prawej Ansari et al.

Summary: Diabetes Mellitus is a metabolic disorder that is spreading rapidly worldwide. Quercetin, a flavonoid, has therapeutic potential in the management of Type-2 DM, as it improves pancreatic beta-cell function, inhibits inflammation, and shows antidiabetic effects.

LIFE-BASEL (2022)

Article Neurosciences

Advanced glycation end products induce Aβ1-42 deposition and cognitive decline through H19/miR-15b/BACE1 axis in diabetic encephalopathy

Lei Jiang et al.

Summary: In this study, the role of advanced glycation end products (AGEs) in the pathogenesis of diabetic encephalopathy (DE) and its underlying mechanisms were investigated. The study found that AGEs induced A81-42 deposition and cognitive decline through the H19/miR15b/BACE1 axis in DE. MiR-15b was downregulated, while H19 and BACE1 were upregulated in the hippocampus of DE rats and AGEs-treated HT-22 cells. The expression of BACE1 protein was negatively regulated by miR-15b at the post-transcriptional level in HT-22 cells. The administration of miR-15b mimics improved cognitive decline in DE rats. The luciferase activity assay confirmed the binding site of miR15b to both the 3'-untranslated region (3'-UTR) of BACE1 mRNA and H19. In addition, the miR-15b inhibitor reversed H19 knockdown-mediated decrease of A81-42 level in AGEs-treated HT-22 cells.

BRAIN RESEARCH BULLETIN (2022)

Article Biochemistry & Molecular Biology

Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent

Fahaad Alenazi et al.

Summary: The combination of metformin and glycation-derived synthesized gold nanoparticles (MTF-GNPs) shows significant antiglycating capacity and may serve as a promising treatment for AGE-related and metabolic disorders.

CELL BIOCHEMISTRY AND FUNCTION (2022)

Article Biochemistry & Molecular Biology

D-ribose-mediated glycation of fibrinogen: Role in the induction of adaptive immune response

Sultan Alouffi et al.

Summary: The nonenzymatic reaction between reducing sugars and amino groups of proteins leads to the formation of advanced glycation end products, which are associated with chronic progressive diseases. This study found that D-ibose-glycated fibrinogen is more immunogenic than its native form and can induce an immune response. The immune response to Rb-gly-Fb resulted in the deposition of antibodies in the glomerular basement membrane of the kidneys and increased expression of proinflammatory cytokine genes.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Article Biochemistry & Molecular Biology

Glycation of Immunoglobulin-G from Pentose Sugar: A Cause for Structural Perturbations

Fahaad Alenazi et al.

Summary: This study analyzed the effects of deoxyribose-induced IgG glycation on IgG structure and AGEs formation. The experimental results confirmed the modification in IgG structure and the formation of AGEs, which may contribute to secondary complications of diabetes.

CURRENT PROTEIN & PEPTIDE SCIENCE (2022)

Article Biochemistry & Molecular Biology

Mineralocorticoid interaction with glycated albumin downregulates NRF-2 signaling pathway in renal cells: Insights into diabetic nephropathy

Deepesh D. Gaikwad et al.

Summary: This study discovers that the interaction between aldosterone and glycated albumin in diabetic nephropathy can cause oxidative stress, reduce levels of antioxidants and glycation detoxifying enzymes, and result in renal cell damage.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Biochemistry & Molecular Biology

Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies

Nilima S. Bangar et al.

Summary: Glycation refers to the reaction between reducing sugars and free amino groups in proteins, resulting in the formation of various products. Glycation plays a significant role in metabolic diseases, brain disorders, aging, and gut microbiome dysregulation. It affects the development of diseases by altering protein structure and function.

GLYCOBIOLOGY (2022)

Article Cell Biology

In vitro differentiation of human pancreatic duct-derived PANC-1 cells into β-cell phenotype using Tinospora cordifolia

Hemangee Damame et al.

Summary: This study evaluated the potential of Tinospora cordifolia extract in inducing differentiation of PANC-1 cells into functional beta cells. The results showed that the extract effectively promoted the formation of beta cells and increased insulin expression and secretion.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2022)

Article Nutrition & Dietetics

Rapid pretreatment for multi-sample analysis of advanced glycation end products and their role in nephropathy

Sayuri Kato et al.

Summary: This study developed a highly efficient automated analysis system for advanced glycation end products (AGEs) and applied it to evaluate AGEs in nephropathy. The results demonstrate that the system performs well in column operations and pretreatment stability, and can accurately measure the levels of AGEs. Furthermore, the study results indicate that the levels of N-epsilon-(carboxymethyl)lysine (CML) and N-epsilon-(carboxyethyl)lysine (CEL) are associated with declined kidney function and significantly elevated in patients with nephropathy.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2022)

Article Nutrition & Dietetics

Food-Related Carbonyl Stress in Cardiometabolic and Cancer Risk Linked to Unhealthy Modern Diet

Carla Iacobini et al.

Summary: Carbonyl stress refers to the increase in reactive carbonyl species and the formation of irreversible covalent adducts with biological molecules. It is associated with inflammation and damage, and plays a role in diabetic cardiovascular complications, cancer risk, and the impact of modern diet on cardiometabolic and cancer risk.

NUTRIENTS (2022)

Article Endocrinology & Metabolism

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study

M. Piazza et al.

Summary: The study found that irbesartan treatment does not alter plasma levels of dicarbonyls in patients with type 2 diabetes, indicating the need for alternative approaches to reduce systemic dicarbonyls in this population.

DIABETIC MEDICINE (2021)

Review Medicine, Research & Experimental

Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease

Periyanaina Kesika et al.

Summary: Gut microbiota plays a crucial role in the development of Alzheimer's disease (AD) through dysbiosis, leading to inflammatory signaling pathway disturbances that promote neuroinflammation and neuronal death. Understanding the relationship between gut microbiota and CNS can help identify probiotic-based supplementation as a potential therapeutic option for AD.

LIFE SCIENCES (2021)

Article Neurosciences

Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor

Gudrian Ricardo Lopes de Almeida et al.

Summary: MGO, an endogenous toxin produced during glycolysis, has been linked to aging, Alzheimer's disease, and inflammation. In vivo administration of MGO affects monoaminergic systems in the cerebral cortex, leading to depression-like behavior and cognitive impairment. Treatment with a dopamine/noradrenaline reuptake inhibitor can reverse these effects.

MOLECULAR NEUROBIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Glyoxal damages human aortic endothelial cells by perturbing the glutathione, mitochondrial membrane potential, and mitogen-activated protein kinase pathways

Ming-Zhang Xie et al.

Summary: Exposure to glyoxal was found to be linked to abnormal glutathione activity, the collapse of mitochondrial membrane potential, and the activation of mitogen-activated protein kinase pathways. However, DNA damage and thioredoxin oxidation were not induced by dialdehydes. These findings provide novel insights into the molecular mechanisms perturbed by glyoxal, and may facilitate the development of new therapeutics and diagnostic markers for cardiovascular diseases.

BMC CARDIOVASCULAR DISORDERS (2021)

Article Biochemistry & Molecular Biology

Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress

Firoz Akhter et al.

Summary: The accumulation of metabolites associated with aging can lead to oxidative stress and mitochondrial dysfunction in the brain, but scavenging mitochondrial ROS can help reduce AGEs and dicarbonyls accumulation, improving mitochondrial function.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Gastroenterology & Hepatology

The Microbiota-Gut-Brain Axis: From Motility to Mood

Kara G. Margolis et al.

Summary: The gut-brain axis is crucial in maintaining homeostasis, with the microbiome playing a significant role in modulating signaling along this axis. This axis impacts disorders like irritable bowel syndrome and mood disorders, with serotonin being a key neurotransmitter involved in these conditions. More research is needed before these findings can be applied for diagnostic and therapeutic purposes in patient populations.

GASTROENTEROLOGY (2021)

Article Food Science & Technology

Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice

M. Pucci et al.

Summary: The study demonstrated that high MG oral intake directly affects brain health and may establish an environment predisposing to AD-like pathological conditions.

FOOD AND CHEMICAL TOXICOLOGY (2021)

Article Biochemistry & Molecular Biology

Glycation of Host Proteins Increases Pathogenic Potential of Porphyromonas gingivalis

Michal Smiga et al.

Summary: The study found that glycation increases the ability of Porphyromonas gingivalis to acquire heme from hemoglobin and promotes bacterial biofilm formation, thus enhancing its pathogenic potential in vivo.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia

Jinluan Chen et al.

Summary: The study found that the AGE-RAGE system is associated with cognitive decline and dementia cross-sectionally but not longitudinally. This suggests a short-term association or reverse causality. Further research is needed to confirm cross-sectional associations between higher skin autofluorescence and cognitive function, as well as the association with APOE status.

JAMA NETWORK OPEN (2021)

Article Immunology

Glycation of gut proteins initiates microbial dysbiosis and can promote establishment of diabetes in experimental animals

Rahul Patil et al.

Summary: The study reveals that high fructose feed can lead to microbial dysbiosis, reducing gut flora and promoting pathogenic succession, thereby exacerbating glycation of gut proteins and triggering an inflammatory response. These changes increase the likelihood of insulin resistance.

MICROBIAL PATHOGENESIS (2021)

Article Neurosciences

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease

Velma T. E. Aho et al.

Summary: This study found that intestinal inflammatory responses and reductions in fecal SCFAs occur in Parkinson's disease (PD), are related to the microbiota and to disease onset, and are not reflected in plasma inflammatory profiles. Some of these relationships are distinct in PD and are sex-dependent. This study revealed potential alterations in microbiota-host interactions and links between earlier PD onset and intestinal inflammatory responses and reduced SCFA levels.

MOLECULAR NEURODEGENERATION (2021)

Article Microbiology

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease

Yan-fang Hou et al.

Summary: The study showed that osteocalcin (OCN) can improve motor deficits and dopaminergic neuronal loss in a Parkinson's disease mouse model. Manipulating the gut microbiome by OCN led to increased propionate levels, which correlated with improvements in motor deficits and dopaminergic neuronal loss in the PD mice. The activation of FFAR3 receptor by propionate in the enteric nervous system might be the main mechanism behind the neuroprotective effects of OCN on Parkinson's disease.

MICROBIOME (2021)

Article Biochemistry & Molecular Biology

Protein glycation ? biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine

Naila Rabbani et al.

Summary: Protein glycation provides a widely used biomarker, A1C, for diagnosing diabetes and prediabetes as well as monitoring medium-term glycemic control in patients with established diabetes. Glycation biomarkers are influenced by various factors such as heritability, aging, decline in metabolic and vascular health, and are applicable to populations of different ethnicities. They have potential for continued and expanding clinical use, including in the era of developing precision medicine.

REDOX BIOLOGY (2021)

Article Food Science & Technology

Role of curd and yogurt in establishment and progression of diabetes through protein glycation and induction of inflammation

Rahul Patil et al.

Summary: The study shows that curd and yogurt can lead to protein glycation and inflammation, causing oxidative stress in animals. Regular consumption of curds can exacerbate diabetes due to glycation of proteins, inflammation, and oxidative stress.

FOOD BIOSCIENCE (2021)

Article Cell Biology

Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease

Zongxin Ling et al.

Summary: The study found that gut dysbiosis in Chinese Alzheimer's disease (AD) patients results in a decrease in bacterial diversity, a reduction in butyrate-producing genera positively correlated with cognitive scores, and an increase in lactate-producing genera inversely correlated with these indicators. This shift in gut dysbiosis contributes to immune disturbances in the host, serving as potential non-invasive biomarkers for distinguishing AD patients from controls. Additionally, altered functional modules in the gut microbiota of AD patients may produce immunomodulatory metabolites.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Epigenetics of Alzheimer's Disease

Matea Nikolac Perkovic et al.

Summary: Validated biomarkers for accurately diagnosing Alzheimer's disease (AD) are currently lacking, but epigenetic modifications have been identified as important factors in the pathogenesis of AD. DNA methylation, hydroxymethylation, histone modifications, and non-coding RNA regulation play critical roles in the development of AD, while mitochondrial DNA may serve as a potential biomarker for AD.

BIOMOLECULES (2021)

Article Neurosciences

Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation

Stefano Romano et al.

Summary: Recent studies have shown significant alterations in the gut microbiome of Parkinson's disease patients compared to healthy individuals, which may result in a pro-inflammatory status and impact the symptoms and pathophysiology of the disease.

NPJ PARKINSONS DISEASE (2021)

Article Food Science & Technology

Methylglyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Inflammation via Interaction with RAGE in Mesangial Cells

Hee-Weon Lee et al.

Summary: The study found that MOLD significantly increases RAGE expression in mouse mesangial cells, leading to ROS production and mitochondrial dysfunction. MOLD activates PI3KB and NF-kappa B signaling pathways, triggering inflammatory responses.

MOLECULAR NUTRITION & FOOD RESEARCH (2021)

Article Endocrinology & Metabolism

Elevated serum pentosidine is independently associated with the high prevalence of sarcopenia in Chinese middle-aged and elderly men with type 2 diabetes mellitus

Xiaofan Zhang et al.

Summary: This study found a negative correlation between serum pentosidine levels and sarcopenia in middle-aged and elderly men with type 2 diabetes mellitus, suggesting that pentosidine could be used as a screening marker for monitoring sarcopenia in patients with type 2 diabetes mellitus.

JOURNAL OF DIABETES INVESTIGATION (2021)

Review Food Science & Technology

Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease

Kensei Taguchi et al.

Summary: Chronic kidney disease affects approximately 10% of the global population and is associated with high frequencies of comorbidities such as heart failure and cardiovascular disease. Gut microbial dysbiosis, an imbalance of the gut microbial community, accelerates CKD progression by producing more uremic toxins in the gastrointestinal tracts. The gut-kidney axis has emerged as a potential therapeutic target for treating CKD.

TOXINS (2021)

Article Endocrinology & Metabolism

Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts

Cecile Guillon et al.

Summary: The study found that glyoxal glycation significantly reduced the proliferation and migration capabilities of fibroblasts, while increasing cellular tensile strength. Glyoxal did not affect the secretion of type I collagen, but disrupted its maturation and prevented deposition in the extracellular matrix, while also promoting the accumulation of lipid droplets.

BMJ OPEN DIABETES RESEARCH & CARE (2021)

Article Food Science & Technology

Highland Barley and Its By-Products Enriched with Phenolic Compounds for Inhibition of Pyrraline Formation by Scavenging α-Dicarbonyl Compounds

Dianwei Zhang et al.

Summary: Pyrraline, a type of advanced glycation end product, can be inhibited by phenolic compounds extracted from highland barley and vinasse. The antioxidant activity of the extracts and their regulation on pyrraline formation were studied using UPLC-PAD-MS/MS. The results suggest that highland barley and its by-products have the potential to be used as functional foods to regulate pyrraline formation during food processing.

FOODS (2021)

Article Nutrition & Dietetics

Increased Added Sugar Consumption Is Common in Parkinson's Disease

Natalie C. Palavra et al.

Summary: The study found that compared to healthy controls, Parkinson's Disease patients consume more total carbohydrates and sugars. PD patients who experience chronic pain, depression, or impulse control disorders consumed more sugars, and increased sugar consumption was associated with worsening non-motor symptoms.

FRONTIERS IN NUTRITION (2021)

Article Clinical Neurology

Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)

Kumar B. Rajan et al.

Summary: This study estimated the prevalence of clinical Alzheimer's disease in 2020 and projected future increases, finding a more significant growth among Hispanics and Blacks.

ALZHEIMERS & DEMENTIA (2021)

Article Biochemistry & Molecular Biology

Detecting beta-amyloid glycation by intrinsic fluorescence-Understanding the link between diabetes and Alzheimer's disease

Abeer Alghamdi et al.

Summary: Monitoring the aggregation of Aβ1-40 in the presence of high glucose concentrations reveals the impact of glycation on oligomerization, altering the aggregation pathway and providing insights into the pathophysiology of Alzheimer's disease. The formation of advanced glycation end products plays a significant role in these pathways, highlighting the connection between AGEs, diabetes, and AD progression.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Review Medical Laboratory Technology

Carbonyl stress in diabetics with acute coronary syndrome

Sushmita Bora et al.

Summary: The prevalence and incidence of diabetes mellitus (DM) are increasing worldwide, leading to higher rates of complications. Mechanisms such as carbonyl stress are responsible for the pathogenesis of DM and its complications, with potential therapeutic targets aimed at minimizing their harmful effects. Extensive research is needed in developing treatment strategies targeting carbonyl stress in patients with diabetes.

CLINICA CHIMICA ACTA (2021)

Review Biochemistry & Molecular Biology

Understanding the Role of Protein Glycation in the Amyloid Aggregation Process

Ivana Sirangelo et al.

Summary: The study provides an overview of the molecular effects induced by glycation on the amyloid aggregation process of protein models associated with misfolding diseases. Glycation plays a key role in protein folding, kinetics of amyloid formation, and amyloid cytotoxicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Physical

Exploring the Impact of Glyoxal Glycation on β-Amyloid Peptide (Aβ) Aggregation in Alzheimer's Disease

Kai-Wei Hu et al.

Summary: The study showed that glycation significantly slows down the aggregation process of A beta and induces more cytotoxicity, especially at position 28. The higher toxicity might result from a relatively stable oligomeric form of the peptide, rather than ROS production.

JOURNAL OF PHYSICAL CHEMISTRY B (2021)

Article Multidisciplinary Sciences

Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration

Chenyin Wang et al.

Summary: This study reveals the critical role of gut microbiota in regulating neurodegenerative diseases, particularly through influencing the formation and aggregation of amyloid fibrils. This provides a new research direction for the treatment of neurodegenerative diseases.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Chemistry, Multidisciplinary

α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques

Nicolo Bisi et al.

Summary: Alpha-synuclein is a highly expressed and conserved protein found in neuronal presynaptic terminals, and its misfolding and aggregation are associated with several neurodegenerative diseases. Studies have shown that the structure of alpha-synuclein can be influenced by various factors, including mutations, biological environment, and interactions with exogenous compounds.

FRONTIERS IN CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Role of Epigenetics in Type 2 Diabetes and Obesity

Rosanna Capparelli et al.

Summary: Epigenetic marks the genome through DNA methylation, histone modification, or non-coding RNAs, guiding cells to respond to environmental cues and maintain stable gene expression. Studies have revealed associations between DNA methylation and conditions such as body mass index, obesity, and Type 2 Diabetes, highlighting the potential therapeutic value of epigenetic research.

BIOMEDICINES (2021)

Article Endocrinology & Metabolism

Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes

Nordin M. J. Hanssen et al.

Summary: The study revealed that plasma MGO levels are associated with adverse outcomes in SLI, showing a strong correlation with mortality and amputation rates in patients.

DIABETES CARE (2021)

Review Clinical Neurology

Parkinson's disease and the gastrointestinal microbiome

Michal Lubomski et al.

JOURNAL OF NEUROLOGY (2020)

Article Chemistry, Medicinal

Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease

Kavya Jash et al.

DRUG DEVELOPMENT RESEARCH (2020)

Review Medical Laboratory Technology

Glycated albumin

Mustapha Zendjabil

CLINICA CHIMICA ACTA (2020)

Article Endocrinology & Metabolism

Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications

Mohamed H. Noureldein et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2020)

Review Biotechnology & Applied Microbiology

Gut, oral and nasal microbiota and Parkinson's disease

Liang Shen

MICROBIAL CELL FACTORIES (2020)

Article Food Science & Technology

The Effect of Lactobacillus fermentum ME-3 Treatment on Glycation and Diabetes Complications

Axel Guilbaud et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2020)

Review Medicine, General & Internal

Role of gut microbiota in type 2 diabetes pathophysiology

Manoj Gurung et al.

EBIOMEDICINE (2020)

Article Cell Biology

Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans

Maria Eugenia Goya et al.

CELL REPORTS (2020)

Review Geriatrics & Gerontology

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease

Gurjit Kaur Bhatti et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein

Hugo Vicente Miranda et al.

FASEB JOURNAL (2020)

Article Endocrinology & Metabolism

The Association between HbA1c Levels, Olfactory Memory and Cognition in Normal, Pre-Diabetic and Diabetic Persons

Burak Yulug et al.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)

Article Clinical Neurology

Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease

Mihai S. Cirstea et al.

MOVEMENT DISORDERS (2020)

Article Biochemistry & Molecular Biology

The Role of Glycation on the Aggregation Properties of IAPP

Giulia Milordini et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Biochemistry & Molecular Biology

Generation and Characterization of Anti-Glucosepane Antibodies Enabling Direct Detection of Glucosepane in Retinal Tissue

Matthew D. Streeter et al.

ACS CHEMICAL BIOLOGY (2020)

Article Clinical Neurology

Meta-Analysisof Gut Dysbiosis in Parkinson's Disease

Hiroshi Nishiwaki et al.

MOVEMENT DISORDERS (2020)

Article Geriatrics & Gerontology

Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer’s disease

Harpreet Kaur et al.

NEUROBIOLOGY OF AGING (2020)

Review Biochemistry & Molecular Biology

RAGE and its ligands: from pathogenesis to therapeutics

Nitish Jangde et al.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Article Neurosciences

Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective

Lee L. Marshall et al.

NATURE NEUROSCIENCE (2020)

Article Pharmacology & Pharmacy

In vitro model using cytokine cocktail to evaluate apoptosis in Min6 pancreatic beta cells

Hemangee H. Damame et al.

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)

Article Neurosciences

Sex specific cognitive differences in Parkinson disease

Tyler Harrison Reekes et al.

NPJ PARKINSONS DISEASE (2020)

Article Endocrinology & Metabolism

Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study

Krishna A. Adeshara et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Article Biochemistry & Molecular Biology

Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide

Yunxiang Sun et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)

Review Neurosciences

Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

D. Allan Butterfield et al.

NATURE REVIEWS NEUROSCIENCE (2019)

Review Neurosciences

Entanglement of Genetics and Epigenetics in Parkinson's Disease

H. J. van Heesbeen et al.

FRONTIERS IN NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Nitration and Glycation Diminish the α-Synuclein Role in the Formation and Scavenging of Cu2+-Catalyzed Reactive Oxygen Species

Humberto Martinez-Orozco et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Review Biophysics

Methylglyoxal - An emerging biomarker for diabetes mellitus diagnosis and its detection methods

Lakshmishri Ramachandra Bhat et al.

BIOSENSORS & BIOELECTRONICS (2019)

Article Biochemistry & Molecular Biology

Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase

Pavel Semenyuk et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)

Article Biochemistry & Molecular Biology

Site-specific glycation of A1-42 affects fibril formation and is neurotoxic

Jin Ng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Gastroenterology & Hepatology

The role of short-chain fatty acids in microbiota-gut-brain communication

Boushra Dalile et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Neurosciences

Do your gut microbes affect your brain dopamine?

Camila Gonzalez-Arancibia et al.

PSYCHOPHARMACOLOGY (2019)

Review Nutrition & Dietetics

Probiotics in Extraintestinal Diseases: Current Trends and New Directions

Despoina E. Kiousi et al.

NUTRIENTS (2019)

Article Biotechnology & Applied Microbiology

Methylglyoxal induces glycation and oxidative stress in Saccharomyces cerevisiae

Rashmi S. Tupe et al.

ANNALS OF MICROBIOLOGY (2019)

Article Multidisciplinary Sciences

Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice

Diana Matheoud et al.

NATURE (2019)

Review Medicine, General & Internal

Microbiome and type 1 diabetes

Heli Siljander et al.

EBIOMEDICINE (2019)

Review Clinical Neurology

A Narrative Review of Lifestyle Factors Associated with Parkinson's Disease Risk and Progression

Nupur Nag et al.

NEURODEGENERATIVE DISEASES (2019)

Letter Clinical Neurology

The gut microbiota: A novel therapeutic target in Parkinson's disease?

Michal Lubomski et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Biochemistry & Molecular Biology

Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats

Rei-ichi Ohno et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Critical Care Medicine

Review of Biguanide (Metformin) Toxicity

George Sam Wang et al.

JOURNAL OF INTENSIVE CARE MEDICINE (2019)

Article Cell Biology

TET2 Regulates the Neuroinflammatory Response in Microglia

Alejandro Carrillo-Jimenez et al.

CELL REPORTS (2019)

Review Geriatrics & Gerontology

Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences

Domenico Sergi et al.

FRONTIERS IN AGING NEUROSCIENCE (2019)

Article Clinical Neurology

Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism

Michela Barichella et al.

MOVEMENT DISORDERS (2019)

Review Gastroenterology & Hepatology

Brain-Gut-Microbiota Axis in Alzheimer's Disease

Karol Kowalski et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2019)

Review Clinical Neurology

Diet in Parkinson's Disease: Critical Role for the Microbiome

Aeja Jackson et al.

FRONTIERS IN NEUROLOGY (2019)

Article Nutrition & Dietetics

Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1-42) injected rats

Somayeh Athari Nik Azm et al.

APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2018)

Article Endocrinology & Metabolism

HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing

Fanfan Zheng et al.

DIABETOLOGIA (2018)

Article Endocrinology & Metabolism

Aberrant intestinal microbiota in individuals with prediabetes

Kristine H. Allin et al.

DIABETOLOGIA (2018)

Review Medicine, General & Internal

Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment

W. Kleinherenbrink et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)

Letter Clinical Neurology

Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial

Joaquin A. Vizcarra et al.

PARKINSONISM & RELATED DISORDERS (2018)

Article Clinical Neurology

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease

Andreas Schwiertz et al.

PARKINSONISM & RELATED DISORDERS (2018)

Article Multidisciplinary Sciences

Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice

Jin Gyu Choi et al.

SCIENTIFIC REPORTS (2018)

Review Neurosciences

Gene Therapy for Parkinson's Disease, An Update

Tobias M. Axelsen et al.

JOURNAL OF PARKINSONS DISEASE (2018)

Article Biochemistry & Molecular Biology

Pioglitazone inhibits advanced glycation induced protein modifications and down-regulates expression of RAGE and NF-κB in renal cells

Krishna A. Adeshara et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)

Article Endocrinology & Metabolism

Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study

Mee Kyoung Kim et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)

Review Biotechnology & Applied Microbiology

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs

Delphine Charvin et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Cell Biology

Current surgical treatments for Parkinson's disease and potential therapeutic targets

Darrin J. Lee et al.

NEURAL REGENERATION RESEARCH (2018)

Article Multidisciplinary Sciences

Parkinson's disease and bacteriophages as its overlooked contributors

George Tetz et al.

SCIENTIFIC REPORTS (2018)

Article Multidisciplinary Sciences

The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

Tommi Vatanen et al.

NATURE (2018)

Article Clinical Neurology

Levodopa-induced dyskinesia in Parkinson disease A population-based cohort study

Pierpaolo Turcano et al.

NEUROLOGY (2018)

Review Neurosciences

Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration

Timothy G. Dinan et al.

JOURNAL OF PHYSIOLOGY-LONDON (2017)

Review Neurosciences

Inflammatory Response in the CNS: Friend or Foe?

Marta Sochocka et al.

MOLECULAR NEUROBIOLOGY (2017)

Review Cell Biology

Human gut microbiota: the links with dementia development

Rashad Alkasir et al.

PROTEIN & CELL (2017)

Article Biochemistry & Molecular Biology

Effective inhibition of protein glycation by combinatorial usage of limonene and aminoguanidine through differential and synergistic mechanisms

Madhav M. Joglekar et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)

Article Neurosciences

Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model

Carolin Brandscheid et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Endocrinology & Metabolism

Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota

Silvia Pellegrini et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Article Biochemistry & Molecular Biology

Methylglyoxal attenuates insulin signaling and downregulates the enzymes involved in cholesterol biosynthesis

Arati B. Deshmukh et al.

MOLECULAR BIOSYSTEMS (2017)

Review Cell Biology

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Cheng Li et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Article Multidisciplinary Sciences

Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila

Shih-Cheng Wu et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation

Juciano Gasparotto et al.

SCIENTIFIC REPORTS (2017)

Article Geriatrics & Gerontology

16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain

David C. Emery et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Review Microbiology

The role of microbial amyloid in neurodegeneration

Robert P. Friedland et al.

PLOS PATHOGENS (2017)

Review Immunology

Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit

Abolghasem Tohidpour et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)

Review Endocrinology & Metabolism

Host-Microbiota Mutualism in Metabolic Diseases

Salvatore Fabbiano et al.

FRONTIERS IN ENDOCRINOLOGY (2017)

Article Neurosciences

Alzheimer's Disease and the Amyloid-β Peptide

M. Paul Murphy et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Multidisciplinary Sciences

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota

T. Harach et al.

SCIENTIFIC REPORTS (2017)

Review Clinical Neurology

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

Eamonn M. M. Quigley

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)

Article Cell & Tissue Engineering

Cell Therapy for Parkinson's Disease

Takao Yasuhara et al.

CELL TRANSPLANTATION (2017)

Article Nutrition & Dietetics

Dietary habits and neurological features of Parkinson's disease patients: Implications for practice

Michela Barichella et al.

CLINICAL NUTRITION (2017)

Article Endocrinology & Metabolism

Metformin Use in Prediabetes Among US Adults, 2005-2012

Eva Tseng et al.

DIABETES CARE (2017)

Article Biochemistry & Molecular Biology

Posttranslational modification impact on the mechanism by which amyloid-β induces synaptic dysfunction

Katarzyna M. Grochowska et al.

EMBO REPORTS (2017)

Review Biochemistry & Molecular Biology

Dynamics of diabetes and obesity: Epidemiological perspective

Annette Boles et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Article Clinical Neurology

Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies

Hugo Vicente Miranda et al.

BRAIN (2017)

Article Biochemistry & Molecular Biology

Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease

Subbiah Pugazhenthi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Review Biochemistry & Molecular Biology

Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal

Ramesh Kandimalla et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Article Medicine, Research & Experimental

Analysis of Gut Microbiota in Patients with Parkinson's Disease

V. A. Petrov et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)

Review Geriatrics & Gerontology

Inflammaging decreases adaptive and innate immune responses in mice and humans

Daniela Frasca et al.

BIOGERONTOLOGY (2016)

Editorial Material Cell Biology

Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes

Adil Mardinoglu et al.

CELL METABOLISM (2016)

Article Biochemistry & Molecular Biology

Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes

Krishna Adeshara et al.

MOLECULAR BIOLOGY REPORTS (2016)

Article Clinical Neurology

Glycation in Parkinson's Disease and Alzheimer's Disease

Hugo Vicente Miranda et al.

MOVEMENT DISORDERS (2016)

Article Multidisciplinary Sciences

Human gut microbes impact host serum metabolome and insulin sensitivity

Helle Krogh Pedersen et al.

NATURE (2016)

Review Multidisciplinary Sciences

Diet-microbiota interactions as moderators of human metabolism

Justin L. Sonnenburg et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice

Vivian M. Choi et al.

NATURE MEDICINE (2016)

Article Clinical Neurology

Gram-negative bacterial molecules associate with Alzheimer disease pathology

Xinhua Zhan et al.

NEUROLOGY (2016)

Article Medicine, General & Internal

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Clinical Neurology

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Marcus M. Unger et al.

PARKINSONISM & RELATED DISORDERS (2016)

Review Multidisciplinary Sciences

Exposing the exposures responsible for type 2 diabetes and obesity

Paul W. Franks et al.

SCIENCE (2016)

Article Cell Biology

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease

Deepak Kumar Vijaya Kumar et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Review Gastroenterology & Hepatology

Human Intestinal Barrier Function in Health and Disease

Julia Konig et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)

Review Endocrinology & Metabolism

Gut microbiota and immune crosstalk in metabolic disease

Remy Burcelin

MOLECULAR METABOLISM (2016)

Article Clinical Neurology

Potential role of antimicrobial peptides in the early onset of Alzheimer's disease

Mick M. Welling et al.

ALZHEIMERS & DEMENTIA (2015)

Article Medicine, General & Internal

Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012 A Retrospective Cohort Study

Tannaz Moin et al.

ANNALS OF INTERNAL MEDICINE (2015)

Article Biochemistry & Molecular Biology

Zinc inhibits glycation induced structural, functional modifications in albumin and protects erythrocytes from glycated albumin toxicity

Rashmi Tupe et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)

Article Clinical Neurology

Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut

Friedrich Leblhuber et al.

JOURNAL OF NEURAL TRANSMISSION (2015)

Article Multidisciplinary Sciences

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

Kristoffer Forslund et al.

NATURE (2015)

Review Biotechnology & Applied Microbiology

Dietary Factors in the Etiology of Parkinson's Disease

Zeynep S. Agim et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

The composition of the gut microbiota shapes the colon mucus barrier

Hedvig E. Jakobsson et al.

EMBO REPORTS (2015)

Review Endocrinology & Metabolism

Prediabetes diagnosis and treatment: A review

Nidhi Bansal

WORLD JOURNAL OF DIABETES (2015)

Review Biochemistry & Molecular Biology

Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

Kerstin Nowotny et al.

BIOMOLECULES (2015)

Article Neurosciences

Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration

Robert P. Friedland

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Clinical Neurology

The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade

Chao Wang et al.

ACTA NEUROPATHOLOGICA (2014)

Article Biochemistry & Molecular Biology

Dicarbonyl proteome and genome damage in metabolic and vascular disease

Naila Rabbani et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2014)

Review Gastroenterology & Hepatology

Intestinal permeability - a new target for disease prevention and therapy

Stephan C. Bischoff et al.

BMC GASTROENTEROLOGY (2014)

Article Neurosciences

Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress

Julio C. Tobon-Velasco et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)

Article Biochemistry & Molecular Biology

Myricitrin Alleviates Methylglyoxal-Induced Mitochondrial Dysfunction and AGEs/RAGE/NF-κB Pathway Activation in SH-SY5Y Cells

Yue-Hua Wang et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2014)

Article Multidisciplinary Sciences

Diet rapidly and reproducibly alters the human gut microbiome

Lawrence A. David et al.

NATURE (2014)

Article Neurosciences

Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease

Katie Lunnon et al.

NATURE NEUROSCIENCE (2014)

Review Geriatrics & Gerontology

Dietary and lifestyle guidelines for the prevention of Alzheimer's disease

Neal D. Barnard et al.

NEUROBIOLOGY OF AGING (2014)

Article Clinical Neurology

Small intestinal bacterial overgrowth in Parkinson's disease

Ai Huey Tan et al.

PARKINSONISM & RELATED DISORDERS (2014)

Editorial Material Multidisciplinary Sciences

Advanced glycation end products, dementia, and diabetes

Simon Lovestone et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Biotechnology & Applied Microbiology

Role of Methylglyoxal in Alzheimer's Disease

Cristina Angeloni et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Public, Environmental & Occupational Health

Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship

Nicholas T. Vagelatos et al.

EPIDEMIOLOGIC REVIEWS (2013)

Article Neurosciences

alpha-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Ane Korff et al.

JOURNAL OF ALZHEIMERS DISEASE (2013)

Article Biochemistry & Molecular Biology

A novel mechanism for antiglycative action of limonene through stabilization of protein conformation

Madhav M. Joglekar et al.

MOLECULAR BIOSYSTEMS (2013)

Article Clinical Neurology

The role of small intestinal bacterial overgrowth in Parkinson's disease

Alfonso Fasano et al.

MOVEMENT DISORDERS (2013)

Article Multidisciplinary Sciences

Richness of human gut microbiome correlates with metabolic markers

Emmanuelle Le Chatelier et al.

NATURE (2013)

Article Multidisciplinary Sciences

Gut metagenome in European women with normal, impaired and diabetic glucose control

Fredrik H. Karlsson et al.

NATURE (2013)

Article Multidisciplinary Sciences

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer's Disease

Niklas K. U. Koehler et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

Amandine Everard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

Vanessa K. Ridaura et al.

SCIENCE (2013)

Review Neurosciences

The Role of Oxidative Stress in Parkinson's Disease

Vera Dias et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Article Medicine, Research & Experimental

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

Rashid Deane et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Immunology

Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia

Ursula Puentener et al.

JOURNAL OF NEUROINFLAMMATION (2012)

Article Multidisciplinary Sciences

A metagenome-wide association study of gut microbiota in type 2 diabetes

Junjie Qin et al.

NATURE (2012)

Article Geriatrics & Gerontology

Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results

Claire Roubaud-Baudron et al.

NEUROBIOLOGY OF AGING (2012)

Review Multidisciplinary Sciences

Genetics and Epigenetics of Parkinson's Disease

Fabio Coppede

SCIENTIFIC WORLD JOURNAL (2012)

Review Nutrition & Dietetics

Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases

William M. Johnson et al.

NUTRIENTS (2012)

Article Biochemistry & Molecular Biology

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress

Alexander Kurz et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2011)

Article Endocrinology & Metabolism

Advanced Glycation End Products Are Direct Modulators of β-Cell Function

Melinda T. Coughlan et al.

DIABETES (2011)

Review Endocrinology & Metabolism

Role of Chronic and Acute Hyperglycemia in the Development of Diabetes Complications

M. Loredana Marcovecchio et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2011)

Article Clinical Neurology

Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease

Maurizio Gabrielli et al.

MOVEMENT DISORDERS (2011)

Article Multidisciplinary Sciences

Enterotypes of the human gut microbiome

Manimozhiyan Arumugam et al.

NATURE (2011)

Review Geriatrics & Gerontology

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease

Velandai Srikanth et al.

NEUROBIOLOGY OF AGING (2011)

Article Biochemistry & Molecular Biology

High fat diet induced diabetic cardiomyopathy

Ellen Dirkx et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)

Article Medicine, Research & Experimental

Neuropathological Alterations in Alzheimer Disease

Alberto Serrano-Pozo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)

Review Neurosciences

Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?

Lana Arab et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Article Food Science & Technology

Fermented milk of Lactobacillus helveticus IDCC3801 reduces beta-amyloid and attenuates memory deficit

Seung-Woo Yeon et al.

JOURNAL OF FUNCTIONAL FOODS (2010)

Article Biochemistry & Molecular Biology

The modification of α-synuclein by dicarbonyl compounds inhibits its fibril-forming process

Daekyun Lee et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)

Article Neurosciences

Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer's Disease

Jannis Kountouras et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2009)

Article Neurosciences

RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-beta-Induced Cellular Perturbation?

Shi Du Yan et al.

JOURNAL OF ALZHEIMERS DISEASE (2009)

Article Endocrinology & Metabolism

Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats

Peter Boor et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2009)

Article Cell Biology

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

Peter J. Turnbaugh et al.

SCIENCE TRANSLATIONAL MEDICINE (2009)

Article Nutrition & Dietetics

Prospective study of dietary pattern and risk of Parkinson disease

Xiang Gao et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)

Article Urology & Nephrology

Reduced expression of insulin receptors in the kidneys of insulin-resistant rats

Swasti Tiwari et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Multidisciplinary Sciences

Microbial ecology - Human gut microbes associated with obesity

Ruth E. Ley et al.

NATURE (2006)

Article Clinical Neurology

Protein intake in parkinsonian patients using the EPIC food frequency questionnaire

Agnieszka Marczewska et al.

MOVEMENT DISORDERS (2006)

Review Biochemistry & Molecular Biology

The gut flora as a forgotten organ

Ann M. O'Hara et al.

EMBO REPORTS (2006)

Article Multidisciplinary Sciences

Metagenomic analysis of the human distal gut microbiome

Steven R. Gill et al.

SCIENCE (2006)

Article Clinical Neurology

Relationship between Helicobacter pylori infection and Alzheimer disease

J Kountouras et al.

NEUROLOGY (2006)

Article Clinical Neurology

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

GJ Biessels et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Review Clinical Neurology

Non-motor symptoms of Parkinson's disease: diagnosis and management

KR Chaudhuri et al.

LANCET NEUROLOGY (2006)

Review Clinical Neurology

Risk of dementia in diabetes mellitus: a systematic review

GJ Biessels et al.

LANCET NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats

I Cherny et al.

JOURNAL OF MOLECULAR BIOLOGY (2005)

Article Endocrinology & Metabolism

Compromised arterial function in human type 2 diabetic patients

EB Okon et al.

DIABETES (2005)

Article Endocrinology & Metabolism

Albumin antioxidant capacity is modified by methylglyoxal

P Faure et al.

DIABETES & METABOLISM (2005)

Review Nutrition & Dietetics

Oxidative stress in childhood - in health and disease states

E Granot et al.

CLINICAL NUTRITION (2004)

Article Medicine, Research & Experimental

High carbohydrate diets and Alzheimer's disease

ST Henderson

MEDICAL HYPOTHESES (2004)

Article Biochemistry & Molecular Biology

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

R Deane et al.

NATURE MEDICINE (2003)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Article Clinical Neurology

Dietary fats and the risk of incident Alzheimer disease

MC Morris et al.

ARCHIVES OF NEUROLOGY (2003)

Review Endocrinology & Metabolism

Advanced glycation end-products: a review

R Singh et al.

DIABETOLOGIA (2001)

Article Biochemistry & Molecular Biology

Crosslinking of α-synuclein by advanced glycation endproducts -: an early pathophysiological step in Lewy body formation?

G Münch et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2000)

Article Neurosciences

LPS-induced neuroinflammatory effects do not recover with time

B Hauss-Wegrzyniak et al.

NEUROREPORT (2000)